Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy

This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of MR001 Combined with Chemotherapy in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC) who have progressed after first-line therapy.

Participants needed: 45
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shenzhen Majory Biotechnology Co., Ltd.Updated: May 26, 2026Locations: 4
Eligibility criteria

Histologically or cytologically confirmed locally advanced or metastatic PDAC, p... [+5]

Known hypersensitivity to MR001 or similar monoclonal antibodies. [+6]

Read more
Status: Recruiting

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of MR001 in patients with advanced triple-negative breast cancer (TNBC) who have progressed after prior therapy.

Participants needed: 42
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shenzhen Majory Biotechnology Co., Ltd.Updated: Feb 12, 2026Locations: 1
Eligibility criteria

Patients with histologically or cytologically confirmed triple-negative breast c... [+6]

History of severe allergy or hypersensitivity to the investigational product or... [+6]

Read more